Hyperliquid Strategies (NASDAQ:PURR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Hyperliquid Strategies (NASDAQ:PURR) to a hold rating in a research note released on Saturday morning.

Several other research firms have also commented on PURR. Chardan Capital upped their price target on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Cantor Fitzgerald raised their price objective on shares of Hyperliquid Strategies from $5.00 to $6.00 and gave the company an “overweight” rating in a research note on Thursday, February 12th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $7.23.

Hyperliquid Strategies Price Performance

NASDAQ:PURR opened at $3.78 on Friday. Hyperliquid Strategies has a 52 week low of $3.01 and a 52 week high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last released its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter. The business had revenue of $0.50 million for the quarter.

Institutional Investors Weigh In On Hyperliquid Strategies

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Boothbay Fund Management LLC bought a new stake in shares of Hyperliquid Strategies during the 4th quarter worth $40,000. XTX Topco Ltd acquired a new position in shares of Hyperliquid Strategies in the 4th quarter valued at $48,000. Squarepoint Ops LLC purchased a new position in Hyperliquid Strategies in the 4th quarter worth about $73,000. Millennium Management LLC acquired a new stake in Hyperliquid Strategies during the 4th quarter worth about $87,000. Finally, Ikarian Capital LLC acquired a new stake in Hyperliquid Strategies during the 4th quarter worth about $107,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.